Albany, NY, June 23, 2015 (GLOBE NEWSWIRE) -- According to a new market report published by Transparency Market Research "E. coli Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2022" the global E. coli testing market was valued at USD 1.2 billion in 2013 and is expected to reach USD 2.1 billion by 2022 at a CAGR of 6.58% from 2014 to 2022.
Water and foodborne diseases are on the rise globally, especially in developing and underdeveloped nations. E. coli has been identified as one of the major causative organisms of water and foodborne diseases. Prevalence of diarrhea and hemolytic uremic syndrome (HUS) are increasing rapidly across the world; these are mostly caused by E. coli infections. Increasing regulatory requirements on water and food used for human consumption have significantly boosted demand for E. coli testing. In 2009, the U.S. FDA adopted a policy wherein bottled water manufacturers must test their water source for potential contaminants such as E. coli. Currently, the bottled water industry accounts for a share of 19% of the total E. coli testing market and is projected to grow at a compound annual growth rate of 6% from 2014 to 2022 due to the adoption of the new government policy.
Browse E. coli Testing Market Research Report With Full TOC @ http://www.transparencymarketresearch.com/e-coli-testing-market.html
The global environmental testing market was valued at USD 103.63 million in 2013 and is expected to reach USD 175.00 million by 2022. Increasing demand for faster and more accurate tests has led to the introduction of new test methods. Rapid test results and accuracy are the other factors that attributed to the higher preference for presence or absence (P/A) tests compared to the most probable number (MPN) tests. The global E. coli clinical testing segment is expected to grow at a CAGR of 6.65% from 2014 to 2022. Factors such as increasing prevalence of a number of food and water borne infectious diseases and growing demand for advanced bacterial diagnostic tests are the primary factors augmenting the market growth.
Browse Press Release of E. coli Testing Market: http://www.transparencymarketresearch.com/pressrelease/global-e-coli-testing-market.htm
Geographically, the global E. coli testing market is segmented as North America, Europe, Asia Pacific, Latin America, Africa and Rest of the World. Bottled water manufacturers account for a share of around 20% of the E. coli testing market in Europe, hence demand for water testing kits is expected to increase in accordance with the growth of the bottled water market. The Europe E. coli testing market was valued at USD 41.28 million in 2013 and is estimated to reach USD 67.90 million by 2022. Consumption of raw food in Japan has been a major factor for spread of foodborne E. coli infections. In 2011, an outbreak of E. coli O111 in central Japan affected more than 50 individuals, resulting in four deaths. The infection was caused due to consumption of raw beef. Water pollution has become a major crisis in China. Thus, owing to all the above mentioned factors the Asia Pacific E. coli testing market is expected to grow at a CAGR of 6.92% from 2014 to 2022.
Request Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4822
The Global E. Coli Testing Market has been Segmented as below:
Global E. coli Testing Market, by Testing Methods
Environmental Testing Market, by Testing Methods
- Membrane Filtration (MF)
- Multiple Tube Fermentation (MTF)
- Enzyme-Substrate Methods
Clinical Testing Market, by Testing Methods
- Polymerase Chain Reaction (PCR) Tests
- Enzyme Immunoassays (EIA)
Global E. coli Testing Market, by End Users
- Home and Drinking Water Suppliers
- Bottled Water Suppliers
- Waste Water Treatment Organizations
- Others (Government Agencies, Private Well Owners, Ground Water Testing, Farm Water Testing, etc.)
Other Reports Published by Transparency Market Research :
- Europe Heparin Market: http://www.transparencymarketresearch.com/europe-heparin-market.html
- Glioblastoma Multiforme Treatment (GBM) Market: http://www.transparencymarketresearch.com/pipeline-review-of-glioblastoma-treatment-market.html
- G-Protein Coupled Receptors (GPCRs) Market: http://www.transparencymarketresearch.com/g-protein-coupled-receptors-market.html
Global E. coli Testing Market, by Geography
- United States
- United Kingdom
- Rest of Europe
- Rest of Asia Pacific
Latin America (LATAM)
- Rest of LATAM
- South Africa
- Rest of Africa
Rest of the World (RoW)
Browse All Biotechnology Market Research Reports: http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
CONTACT: Mr. Nachiket Ghumare State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: firstname.lastname@example.org Website: http://www.transparencymarketresearch.com/
Source:Transparency Market Research